72 related articles for article (PubMed ID: 38491413)
1. Efficacy and safety of proton pump inhibitors (PPIs) plus rebamipide for endoscopic submucosal dissection-induced ulcers: a meta-analysis.
Wang J; Guo X; Ye C; Yu S; Zhang J; Song J; Cao Z; Wang J; Liu M; Dong W
Intern Med; 2014; 53(12):1243-8. PubMed ID: 24930641
[TBL] [Abstract][Full Text] [Related]
2. Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis.
Jiang X; Li J; Xie J; Liang Z; Wan N; Jiang J; Zhang T; Wu Y
Front Pharmacol; 2019; 10():1055. PubMed ID: 31607912
[No Abstract] [Full Text] [Related]
3. Comparison of vonoprazan and proton pump inhibitors for the treatment of gastric endoscopic submucosal dissection-induced ulcer: an updated systematic review and meta-analysis.
Chen L; Jiang D; Hu D; Cui X
BMC Gastroenterol; 2024 Mar; 24(1):110. PubMed ID: 38491413
[TBL] [Abstract][Full Text] [Related]
4. Vonoprazan vs proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: A meta-analysis of randomized controlled trials and observational studies.
Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
Medicine (Baltimore); 2020 Feb; 99(9):e19357. PubMed ID: 32118778
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of vonoprazan for management of post-endoscopic submucosal dissection ulcers compared with proton pump inhibitors: A meta-analysis.
Liu C; Feng BC; Zhang Y; Li LX; Zuo XL; Li YQ
J Dig Dis; 2019 Oct; 20(10):503-511. PubMed ID: 31414725
[TBL] [Abstract][Full Text] [Related]
6. Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer: A systematic review with meta-analysis.
Kang H; Kim BJ; Choi G; Kim JG
Medicine (Baltimore); 2019 Jun; 98(24):e15860. PubMed ID: 31192917
[TBL] [Abstract][Full Text] [Related]
7. Vonoprazan versus proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: Protocol for meta-analysis of randomized controlled trials and observational studies.
Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
Medicine (Baltimore); 2019 Feb; 98(8):e14381. PubMed ID: 30813139
[TBL] [Abstract][Full Text] [Related]
8. Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: A propensity score-matching analysis.
Maruoka D; Arai M; Kasamatsu S; Ishigami H; Taida T; Okimoto K; Saito K; Matsumura T; Nakagawa T; Katsuno T; Yokosuka O
Dig Endosc; 2017 Jan; 29(1):57-64. PubMed ID: 27492962
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the widths of the mucosal strips in pathological examination of specimens of endoscopic submucosal dissection for early gastric cancer.
Katsuragi SY; Otsuki Y; Unno S; Kimata M; Yoshizawa Y; Tomatsu M; Shinmura K; Suzuki K; Sugimura H
Gastric Cancer; 2023 Sep; 26(5):755-762. PubMed ID: 37170005
[TBL] [Abstract][Full Text] [Related]
10. Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis.
Xu W; Bai Z; Shang Y; Wang J; Wong Y; Qi X
Therap Adv Gastroenterol; 2023; 16():17562848231167858. PubMed ID: 37113190
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic submucosal dissection techniques and technology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Review.
Libânio D; Pimentel-Nunes P; Bastiaansen B; Bisschops R; Bourke MJ; Deprez PH; Esposito G; Lemmers A; Leclercq P; Maselli R; Messmann H; Pech O; Pioche M; Vieth M; Weusten BLAM; Fuccio L; Bhandari P; Dinis-Ribeiro M
Endoscopy; 2023 Apr; 55(4):361-389. PubMed ID: 36882090
[TBL] [Abstract][Full Text] [Related]
12. Short-term outcomes of endoscopic submucosal dissection for the treatment of superficial gastric neoplasms in non-Asian countries: a systematic review and meta-analysis.
Benites-Goñi H; Palacios-Salas F; Marín-Calderón L; Diaz-Arocutipa C; Piscoya A; Hernandez AV
Ann Gastroenterol; 2023; 36(2):167-177. PubMed ID: 36864932
[TBL] [Abstract][Full Text] [Related]
13. Vonoprazan versus proton pump inhibitors for postendoscopic submucosal dissection bleeding in the stomach: a multicenter population-based comparative study.
Shiratori Y; Niikura R; Ishii N; Ikeya T; Honda T; Hasatani K; Yoshida N; Nishida T; Sumiyoshi T; Kiyotoki S; Arai M; Kawai T; Fukuda K
Gastrointest Endosc; 2022 Jan; 95(1):72-79.e3. PubMed ID: 34237329
[TBL] [Abstract][Full Text] [Related]
14. Vonoprazan vs lansoprazole for the treatment of artificial gastric ulcer after endoscopic submucosal dissection: a prospective randomized comparative study.
Ban H; Inatomi O; Murata M; Otsuka T; Oi M; Matsumoto H; Bamba S; Andoh A
J Clin Biochem Nutr; 2021 May; 68(3):259-263. PubMed ID: 34025030
[TBL] [Abstract][Full Text] [Related]
15. Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial.
Kawai D; Takenaka R; Ishiguro M; Okanoue S; Gotoda T; Kono Y; Takemoto K; Tsugeno H; Fujiki S
BMC Gastroenterol; 2021 May; 21(1):236. PubMed ID: 34022796
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
